{
    "nctId": "NCT00232479",
    "briefTitle": "Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer",
    "officialTitle": "Phase II Study of Dose Dense Carboplatin and Taxotere With Herceptin As Primary Systemic Therapy in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 48,
    "primaryOutcomeMeasure": "Number of Patients With Pathologic Complete Response (pCR)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* HER-2 overexpressing breast cancer\n* Clinical stage 2-3B\n* Normal ejection fraction\n\nExclusion Criteria:\n\n* Metastatic disease\n* Low ejection fraction",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}